跳至主要内容
临床试验/NCT06806098
NCT06806098已完成不适用

Cessation Clinical Trial

Truth Initiative2 个研究点 分布在 1 个国家目标入组 1,555 人开始时间: 2024年12月5日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,555
试验地点
2
主要终点
30-day point prevalent abstinence

研究概览

简要总结

The Cessation Clinical Trial will investigate the effectiveness of a digital quit tobacco program in promoting abstinence from tobacco product use compared to usual care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Data collection staff will be blinded to study condition.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Current tobacco use (past 30-day use of one or more of the following: cigarettes, cigars, little cigars, cigarillos, e-cigarettes, or oral nicotine products)
  • US residence
  • Active text message plan (phase 2 only)

排除标准

  • Age 25 or above (phase 2 only)

研究组 & 干预措施

Sponsored cessation intervention

Experimental

Intervention arm receiving sponsored version only available for enterprise client users.

干预措施: Truth Initiative Digital Cessation Program (Behavioral)

Usual Care

Active Comparator

Usual care control arm receiving referral to a free digital cessation program

干预措施: Usual Care (Behavioral)

结局指标

主要结局

30-day point prevalent abstinence

时间窗: 7-months post randomization

30-day point prevalent abstinence from user's primary product to quit indicated at enrollment

次要结局

  • Abstinence from all tobacco products(7 months post randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amanda L. Graham, PhD

Chief Health Officer

Truth Initiative

研究点 (2)

Loading locations...

相似试验